Serono Symposia International Foundation (SSIF) "The Biological Basis of Progressive MS"

By Serono Symposia International Foundation, PRNE
Thursday, November 4, 2010

Towards Improvement of Future Management of Progressive Forms of MS

ROME, November 5, 2010 - Some of the most experienced clinicians and scientists working
in the field of multiple sclerosis will gather in Montreal on November the
6th during the Symposium- "The biological basis of progressive MS held by
Serono Symposia International Foundation," in order to discuss the most
recent developments and discuss the future management of progressive MS.

(Logo: )

Participants in this Symposium will be updated on the latest
developments on the pathophysiology of the progressive forms of MS, discuss
current and future innovative options for their treatment, and be informed
about the most recent and innovative diagnostic approaches.

Multiple sclerosis results from the interplay of two clinical
processes, relapses and progression. The three main clinical forms may be
identified as relapsing-remitting (RRMS), secondary progressive (SPMS) and
primary progressive (PPMS). The last decades have allowed the development of
clinical databasing and the assembly of large cohorts of persons with MS.
These sustained efforts have led to major advances in the knowledge of
several key clinical aspects of MS, notably the assessment of the weight of
relapses and the long term accumulation of irreversible disability.

We are moving towards a new era in the management of the less
severe form of MS, when more specific therapies will be able to markedly
reduce, or suppress, disease activity. Although physicians and scientists
working in multiple sclerosis have devoted enormous efforts to studying the
progressive forms of MS, many aspects of this process remain obscure and a
challenging issue for health care professionals, as well as a heavy burden
for patients.

"By assembling some of the most experienced scientists in the
field," said Pierre Duquette, Service de Neurologie Hôpital Notre Dame,
Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec
Canada, one of the Scientific Organizers of the event, "we intend to discuss
what has been recently achieved and propose solutions for improving the
management of the progressive forms of MS in research and clinical practice."

"More deeply," added Jack Antel, Departement of Neurology and
Neurosurgery Montreal Neurological Institute, McGill University, Montreal,
Québec, Canada, Scientific Organizer along with P. Duquette, "during the
Panel on Future Therapies will discuss and identify short and long term
opportunities and challenges that will be central to the development of
effective therapeutic strategies to prevent, slow or reverse the progressive
phases of MS."

"As Continuing Medical Education Partner, Serono Symposia
International Foundation is committed to offer its know-how in the
International scenario," said Jean Daniel Baki, Board Member and Secretary of
the Board of Serono Symposia International Foundation, "and more even so in
Canada in order to support the local efforts in organizing scientific
educational panels and events tailored for Canadian Health care professionals
and clinicians."

Serono Symposia International Foundation is a non-profit
organization based in Geneva (Switzerland). It was founded to disseminate the
most innovative achievements and potential developments of medical and
scientific research through conferences, training courses, online courses and
publications. In particular, it provides Continuing Medical Education for
doctors and healthcare professionals by organizing high-level scientific
programs. Over the past four decades Serono Symposia International Foundation
has organized more than 1500 international scientific congresses and
published more than 500 proceedings with the most important international

Ufficio stampa

    GAS Communication
    Chiara Ippoliti
    Tel. +39-0668134260 - fax +39-0668134876

GAS Communication, Chiara Ippoliti, Tel. +39-0668134260 - fax +39-0668134876, c.ippoliti at

will not be displayed